HomeMarkets overviewSharesGilead Sciences Inc

Trade Gilead Sciences Inc - GILD CFD

Market is not available at the momentMarket information is presented
as of 2026-09-15T23:45:52+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread1.05
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.021485 %
(-$4.30)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $19,000.00


-0.02149%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.000738 %
(-$0.15)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $19,000.00


-0.00074%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity0.1
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close145.65
Open145.06
1-Year Change29.71%
Day's Range143.01 - 146.33

Trade Gilead Sciences Inc - GILD

What is Gilead Sciences Inc (GILD)?

Gilead Sciences Inc is a biopharmaceutical company focused on the research, development, and commercialization of innovative medicines. The company specializes in antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, among other viral infections. Gilead's portfolio includes therapies for oncology, inflammatory diseases, and cardiovascular conditions, reflecting its commitment to addressing unmet medical needs. The company operates globally, with research facilities and commercial operations spanning multiple countries. Gilead invests significantly in scientific research and clinical development to advance its pipeline of therapeutic candidates. Its approach integrates cutting-edge science with strategic partnerships and acquisitions to enhance its product offerings. The company also emphasizes access to medicines and collaborates with healthcare providers and organizations worldwide to improve patient outcomes. Gilead Sciences Inc is recognized for its contributions to antiviral therapy and continues to play a prominent role in the pharmaceutical industry through ongoing innovation and development.

Gilead Sciences Inc Stock Price Today: Live Overview

The price today is shaped by ongoing market fluctuations, as Gilead Sciences Inc trades at $146.8. It has ranged between $145.75 and $145.99, reflecting a daily change of +0.1717%.

FAQ: Gilead Sciences Inc (GILD)

What is the current price of GILD stock?

Gilead Sciences Inc's stock price is $146.8.

Does GILD pay dividends?

Gilead Sciences Inc pays dividends via cash distributions (if applicable).

Does GILD have a formal corporate presence or regional headquarters in the UAE?

Gilead Sciences Inc operates in the UAE via partners and distributors without a direct office.

What is GILD best known for?

Gilead Sciences Inc is most famous for its antiviral drugs and therapies.

What assets are typically shown together with GILD?

Commonly shown alongside GILD: Datang Power, FOX - Class B, Invesco Galaxy Bitcoin Etf

Latest shares articles

Intel stock forecast: PC processor price increase
Intel is a US semiconductor company. In September 2026, reports said it planned a roughly 10% increase in PC processor prices from 5 October. Explore third-party INTC price targets and technical analysis. Past performance is not a reliable indicator of future results.
17 hours ago
Neinor Homes stock forecast: buybacks, post-AEDAS investment
Neinor Homes is a Spanish residential developer. In September 2026, it disclosed €3.63m in share buybacks and plans for more than €350m in post-AEDAS investment. Explore third-party HOME price targets and technical analysis. Past performance is not a reliable indicator of future results.
21 hours ago
Nebius stock forecast: Palantir sovereign AI partnership
Nebius Group is an AI infrastructure company. In September 2026, Palantir named Nebius its preferred sovereign AI infrastructure partner. Explore third-party NBIS price targets and technical analysis. Past performance is not a reliable indicator of future results.
22 hours ago
Grenergy Renovables stock forecast: Gabriela project sale
Grenergy Renovables is a Spanish renewable-energy company. In September 2026, it completed the €409m sale of its Gabriela solar and battery storage project in Chile to CVC DIF. Explore third-party GRE targets and technicals. Past performance is not a reliable indicator of future results.
22 hours ago

User feedback and ratings

2025-07-01
Victor Flemming Nandwa Søder

Great customer service I got to say that. They helped get my account back very fast, after i logged myself out by losing my old email, it was so fast you wouldn’t believe it thank you once again.

2025-07-01
Perry Reineke

I'm learning the basics of stock investing. This platform is clear and pretty good. I've been using it for over 6 months.

2025-06-29
proinpro

Capital is really great to be used on start, also beginner friendly broker! Great costumer support and it is quick!

2025-06-27
Gio Gvazava

Capital.com has been great for both learning and trading. The app is clean, fast, and packed with useful tools. Customer support has been solid too. Definitely recommended for beginners and active traders alike.

2025-06-27
Douglas

Deposits and withdrawals work without issues. Very low spreads. No noticeable fees. Easy to follow.

2025-06-22
Jean A.

The app is built to make options and figures easy to understand, great for beginners and intermediate traders. Demo accounts are simple to set up. 100:1 leverage is available.

2025-06-19
foobarbeer

I am extremely happy with this broker. Great spreads, good selection of instruments, well coded toolbox.

2025-06-19
Casaubon70

Love the TV integration. Makes traders life smooth and comfortable.

2025-06-19
dgogidze7

I would like to express a huge thank you to Evgeniya Logvinovich, customer service manager. For your attention and heartfelt attitude to your clients.❤️

2025-05-30
Brigman

Everything worked as expected from the 1 day. I didn’t have to search how to use the platform, it’s intuitive. The support chat was there when I had a tiny issue.

2025-05-24
Radioilluminati

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-05-20
GemzT

I’d been paper trading for 2yrs now, went live and this platform is easy for beginners to understand and navigate all important tools to execute all that I learned. Earning now!

2025-04-29
dmjnoor

This application is perfect.. simple, easy to use, run smoothly and fast and it has an accurate graphics.. be careful to use only one credit card and one bank account to prevent any withdrawal problem.. overnight fees and spread variation will be repaid for you by the next month.. I used many application but this is the best one

2025-03-24
Debbie P

The best trading company I've found so far and so easy to use.

2025-02-06
Nouman Butt

User friendly app & interface and good support team. Funds transfer ease & Leverage is an advantage but crypto is highly risky be responsible of your loss limits and risks appetite.

Showing our 4 & 5 star reviews.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready